Post-Marketing Studies play an integral role in gathering information about safety and efficacy on a large scale. However, monitoring adverse events and patient-reported outcomes in a real-world setting can be challenging.

Following a successful launch in Europe in 2019, and a tremendous online experience in 2021, the 3rd Dermatology Drug Development Europe Summit, returns in April 2022 in Frankfurt, Germany.

Digitalization and telemedicine have shown significant advancements in the medical industry. Still, clinical research will continue to need high-quality tools to conduct trials efficiently and decrease strain on patients.